These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1070 related articles for article (PubMed ID: 15686220)

  • 1. [Contemporary status of BCG vaccine in the world and in Serbia].
    Pesut D
    Med Pregl; 2004; 57 Suppl 1():37-40. PubMed ID: 15686220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BCG vaccination in the world].
    Toida I
    Kekkaku; 2000 Jan; 75(1):1-7. PubMed ID: 10689812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
    Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
    Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of BCG vaccination policy in Europe: 1994-96.
    Trnka L; Dankova D; Zitova J; Cimprichova L; Migliori GB; Clancy L; Zellweger JP
    Bull World Health Organ; 1998; 76(1):85-91. PubMed ID: 9615500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the literature on the economics of vaccination against TB.
    Tu HA; Vu HD; Rozenbaum MH; Woerdenbag HJ; Postma MJ
    Expert Rev Vaccines; 2012 Mar; 11(3):303-17. PubMed ID: 22380823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccine prophylaxis of tuberculosis: implication and problems].
    Aksenova VA; Levi DT; Fonina EV; Vundtsettel' NN
    Probl Tuberk Bolezn Legk; 2009; (1):10-6. PubMed ID: 19253677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative evaluation of the effectiveness of vaccination of newborn infants with BCG and BCG-M vaccines].
    Mitinskaia LA; Demeshko ND; Efimova AA; Litseva OA; Iablokova TB; Levi DT; Pisarenko NN; Kogan ES
    Probl Tuberk; 1990; (12):3-5. PubMed ID: 2084688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
    Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six years' experience with the discontinuation of BCG vaccination. 1. Risk of tuberculosis infection and disease.
    Trnka L; Danková D; Svandová E
    Tuber Lung Dis; 1993 Jun; 74(3):167-72. PubMed ID: 8369510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial.
    Barreto ML; Pereira SM; Pilger D; Cruz AA; Cunha SS; Sant'Anna C; Ichihara MY; Genser B; Rodrigues LC
    Vaccine; 2011 Jul; 29(31):4875-7. PubMed ID: 21616115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
    Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis prevention needs adaptation to conditions of Central European countries].
    Trnka L; Dankova D
    Probl Tuberk; 1993; (4):11-3. PubMed ID: 8127823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of the BCG vaccination in Hungary since 1929: evaluation of preventive and immunotherapeutic effectiveness].
    Lugosi L
    Orv Hetil; 1998 Jun; 139(26):1563-70. PubMed ID: 9676117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil.
    Dantas OM; Ximenes RA; de Albuquerque Mde F; da Silva NL; Montarroyos UR; de Souza WV; Pereira TC; Campelo AR; Rodrigues LC
    Int J Tuberc Lung Dis; 2006 May; 10(5):536-41. PubMed ID: 16704036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG in Finland: changing from a universal to a selected programme.
    Salo EP
    Euro Surveill; 2006; 11(3):18-20. PubMed ID: 16567879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.